Sacral neuromodulation for symptomatic chronic urinary retention in females: do age and comorbidities make a difference?

Objectives To evaluate if age and medical comorbidities are associated with progression to implantation of sacral neuromodulation devices in women with symptomatic chronic urinary retention. Methods This multisite retrospective cohort included women with symptomatic chronic urinary retention who had...

Full description

Saved in:
Bibliographic Details
Published inInternational Urogynecology Journal Vol. 32; no. 10; pp. 2703 - 2715
Main Authors High, Rachel A., Winkelman, William, Panza, Joseph, Sanderson, Derrick J., Yuen, Hyde, Halder, Gabriela E., Shaver, Courtney, Bird, Erin T., Rogers, Rebecca G., Danford, Jill M.
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.10.2021
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objectives To evaluate if age and medical comorbidities are associated with progression to implantation of sacral neuromodulation devices in women with symptomatic chronic urinary retention. Methods This multisite retrospective cohort included women with symptomatic chronic urinary retention who had a trial phase of sacral neuromodulation. The primary outcome was progression to implantation. Post-implantation outcomes were assessed as stable response versus decreased efficacy. A sub-analysis of catheter-reliant (intermittent-self catheterization or indwelling) patients was performed. Age was analyzed by 10-year units (decades of age). Multivariate logistic regression determined odds ratios for outcomes of implantation and for post-implantation stable response. Results Implantation occurred in 86% (243/284) women across six academic institutions. Most patients (160/243, 66%) were catheter reliant at the time of trial phase. Increased decade of age was associated with reduced implantation in all women [OR 0.54 (95% CI 0.42, 0.70)] and in the subgroup of catheter-reliant women [OR 0.52 (95% CI 0.37, 0.73)]. Post-implantation stable response occurred in 68% (193/243) of women at median follow-up of 2 years (range 0.3–15 years). Medical comorbidities present at the time of trials did not impact progression to implantation or post-implantation success. Conclusions Increasing decade of age is associated with reduced implantation in women with symptomatic chronic urinary retention. There is no age cutoff at which outcomes change. Post-implantation stable response was not associated with age or medical comorbidities.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0937-3462
1433-3023
DOI:10.1007/s00192-020-04485-0